Back to top

Image: Bigstock

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Read MoreHide Full Article

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the metrics and results to consider, earnings is one of the most important.

Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.

Now that we know how important earnings and earnings surprises are, it's time to show investors how to take advantage of these events to boost their returns by utilizing the Zacks Earnings ESP filter.

The Zacks Earnings ESP, Explained

The Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information.

The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction. The Zacks Rank is also factored into the ESP metric to better help find companies that appear poised to top their next bottom-line consensus estimate, which will hopefully help lift the stock price.

When we join a positive earnings ESP with a Zacks Rank #3 (Hold) or stronger, stocks posted a positive bottom-line surprise 70% of the time. Plus, this system saw investors produce roughly 28% annual returns on average, according to our 10 year backtest.

Stocks with a ranking of #3 (Hold), or 60% of all stocks covered by the Zacks Rank, are expected to perform in-line with the broader market. Stocks with rankings of #2 (Buy) and #1 (Strong Buy), or the top 15% and top 5% of stocks, respectively, should outperform the market; Strong Buy stocks should outperform more than any other rank.

Should You Consider Regeneron?

The final step today is to look at a stock that meets our ESP qualifications. Regeneron (REGN - Free Report) earns a #3 (Hold) 29 days from its next quarterly earnings release on May 3, 2023, and its Most Accurate Estimate comes in at $10.13 a share.

Regeneron's Earnings ESP sits at +6.78%, which, as explained above, is calculated by taking the percentage difference between the $10.13 Most Accurate Estimate and the Zacks Consensus Estimate of $9.49. REGN is also part of a large group of stocks that boast a positive ESP. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

REGN is just one of a large group of Medical stocks with a positive ESP figure. Amgen (AMGN - Free Report) is another qualifying stock you may want to consider.

Slated to report earnings on April 26, 2023, Amgen holds a #3 (Hold) ranking on the Zacks Rank, and it's Most Accurate Estimate is $4.50 a share 22 days from its next quarterly update.

The Zacks Consensus Estimate for Amgen is $3.93, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of +14.54%.

REGN and AMGN's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Regeneron Pharmaceuticals, Inc. (REGN) - free report >>

Amgen Inc. (AMGN) - free report >>

Published in